Search

everythinglearnresearchcommunity

for

Search:↓

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Mesenchymal stem cells are key to future tissue regeneration in oral surgery.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Alopecia areata treatment varies, with no optimal method established yet.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.